Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1979 1
1982 3
1983 1
1985 1
1986 3
1987 1
1989 1
1993 2
1994 1
1995 2
1996 2
1997 2
1998 2
1999 4
2000 10
2001 3
2002 2
2003 6
2004 4
2005 2
2006 3
2007 5
2008 2
2009 4
2010 4
2011 6
2012 7
2013 7
2014 9
2015 7
2016 5
2017 11
2018 18
2019 15
2020 34
2021 24
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.
Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, Demos M, Gustine J, Chan G, Munshi M, Tsakmaklis N, Chen JG, Kofides A, Sklavenitis-Pistofidis R, Bustoros M, Keezer A, Meid K, Patterson CJ, Sacco A, Roccaro A, Branagan AR, Yang G, Ghobrial IM, Castillo JJ. Treon SP, et al. Among authors: munshi m. J Clin Oncol. 2020 Apr 10;38(11):1198-1208. doi: 10.1200/JCO.19.02314. Epub 2020 Feb 21. J Clin Oncol. 2020. PMID: 32083995 Free PMC article. Review.
Diabetes in ageing: pathways for developing the evidence base for clinical guidance.
Munshi MN, Meneilly GS, Rodríguez-Mañas L, Close KL, Conlin PR, Cukierman-Yaffe T, Forbes A, Ganda OP, Kahn CR, Huang E, Laffel LM, Lee CG, Lee S, Nathan DM, Pandya N, Pratley R, Gabbay R, Sinclair AJ. Munshi MN, et al. Lancet Diabetes Endocrinol. 2020 Oct;8(10):855-867. doi: 10.1016/S2213-8587(20)30230-8. Lancet Diabetes Endocrinol. 2020. PMID: 32946822 Free PMC article. Review.
Venetoclax in Previously Treated Waldenström Macroglobulinemia.
Castillo JJ, Allan JN, Siddiqi T, Advani RH, Meid K, Leventoff C, White TP, Flynn CA, Sarosiek S, Branagan AR, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Davids MS, Furman RR, Treon SP. Castillo JJ, et al. Among authors: munshi m. J Clin Oncol. 2022 Jan 1;40(1):63-71. doi: 10.1200/JCO.21.01194. Epub 2021 Nov 18. J Clin Oncol. 2022. PMID: 34793256 Clinical Trial.
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance.
Yang G, Wang J, Tan L, Munshi M, Liu X, Kofides A, Chen JG, Tsakmaklis N, Demos MG, Guerrera ML, Xu L, Hunter ZR, Che J, Patterson CJ, Meid K, Castillo JJ, Munshi NC, Anderson KC, Cameron M, Buhrlage SJ, Gray NS, Treon SP. Yang G, et al. Among authors: munshi m. Blood. 2021 Nov 18;138(20):1966-1979. doi: 10.1182/blood.2021011405. Blood. 2021. PMID: 34132782
The susceptibility ring.
Sanghvi D, Redij A, Munshi M, Nakshiwala V. Sanghvi D, et al. Among authors: munshi m. Br J Radiol. 2019 Aug;92(1100):20190034. doi: 10.1259/bjr.20190034. Epub 2019 Jul 9. Br J Radiol. 2019. PMID: 31286795 Free PMC article. No abstract available.
208 results